Subscribe to SPAC Research for full access.
January 30, 2023

New Features: News Filtering By Tags and Portfolios
We're proud to announce some new features on the SPAC Research website.

Our news feed can now be filtered by individual event tags. Want to see only Deal Announcements? News items related to Additional Transaction Financing? How about Super 8-K's?

Play with the filters on the left navigation bar to refine the results to exactly what you're searching for.
We've also added a Portfolios feature where you can build watchlists of individual SPACs.
You can use the briefcase icons (shown below) on the main SPAC Index and many other pages to add SPACs to any of your portfolios.
You can also use our new Agenda View on the calendar page to see a list of upcoming events, which you can refine to only show events related to one of your portfolios.
And you can filter the news feed by items related to any of your portfolios as well.
Please reach out to us if you have any questions about our new features.
News From the Past Week

Deal News

  • Denali Capital Acquisition Corp. (DECA) announced a deal to acquire Longevity Biomedical, Inc., a biopharmaceutical company focused on advancing new technologies across therapeutics, health monitoring and digital health solutions to improve human health. The deal reflects an equity value of $236mm and is expected to close in Q2 2023.

  • DHC Acquisition Corp. (DHCA) terminated its business combination agreement with GloriFi because GloriFi announced it was winding down its operations and closing its digital banking platform and other products.

  • Jack Creek Investment Corp. (formerly JCIC) closed its acquisition of Bridger Aerospace on Tuesday 1/24/2023 with less than 1% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “BAER” and “BAERW.”

  • Health Sciences Acquisitions Corporation 2 (formerly HSAQ) closed its acquisition of Orchestra BioMed on Thursday 1/26/2023. Redemption statistics were not provided. Ordinary shares are now trading on the NASDAQ as “OBIO.”

  • Gesher I Acquisition Corp. (formerly GIAC) closed its acquisition of Freightos on Wednesday 1/25/2023 with 11% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “CRGO” and “CRGOW.”

  • BlueRiver Acquisition Corp. (BLUA) signed an LOI with an unspecified company in the medical technology sector. No timeline for a definitive agreement was given.

  • Insight Acquisition Corp. (INAQ) signed a LOI with Avila Energy Corporation (CSE: VIK), a licensed producer, explorer, and developer of energy in Canada. The transaction assumes an enterprise value of $185mm with no closing timeline given.

  • Decarbonization Plus Acquisition Corporation IV (DCRD) shareholders approved the company’s acquisition of Hammerhead Resources at a meeting Monday 1/23/2023. Redemption statistics were not provided and no closing timeline was given.

  • Noble Rock Acquisition Corporation (NRAC) announced it will transfer its sponsor ownership, change its name, and update its board accordingly. The SPAC's new CEO will be Aemish Shah, the co-founder and managing partner of General Global Capital, a growth-stage tech investment firm.

New S-1's
There were no SPAC S-1's last week.

IPOs
There were no SPAC IPOs last week.

Liquidations
Name Ticker Size ($mm) Announced Liq. Date Trust Per Share
North Atlantic Acq NAAC 380 1/26/2023 1/26/2023 $10.13
FoxWayne Enterprises FOXW 58 1/25/2023 1/27/2023 $10.18
D & Z Media DNZ 288 1/23/2023 2/7/2023 $10.17
G Squared Ascend I GSQD 345 1/25/2023 2/9/2023 $10.18
ScION Tech Growth II SCOB 345 1/25/2023 2/13/2023 $10.20


Registrations Withdrawn
Name Ticker Size ($mm) Underwriter Trust Funding Coverage
C&W Acq CWAC 250 Citi 100.0% 1/4
Constitution Acq USSC 200 Cowen 102.0% 1/2
Twelve Seas IV TSIV 200 Mizuho 102.0% 3/4
VIKASA I VSSA 200 Cantor 102.0% 1/2

Charter Extensions

  • AIB extended its charter through 10/21/2023 with a monthly $0.005 per share sponsor contribution to trust and 12% of public shares remaining.
  • ERES extended its charter through 7/27/2023 with a monthly $0.033 per share sponsor contribution to trust and 8% of public shares remaining.
  • APAC extended its charter through 7/20/2023 with a monthly $0.049 per share sponsor contribution to trust and 15% of public shares remaining.
  • PGSS extended its charter through 4/26/2023 with a single $0.10 per share sponsor contribution to trust.
  • BMAQ extended its charter through 2/21/2023 with a single $0.06 per share sponsor contribution to trust.
  • TETE extended its charter through 7/20/2023 with a monthly $0.053 per share sponsor contribution to trust and 27% of public shares remaining.
  • DCRD extended its charter through 3/13/2023 with no sponsor contribution to trust. Redemption statistics were not provided.
  • BRLI extended its charter through 4/23/2023 with a monthly $0.053 sponsor contribution to trust and 9% of public shares remaining.
  • DHHC extended its charter through 7/28/2023 with no sponsor contribution to trust and 15% of public shares remaining.
  • BIOT extended its charter through 10/27/2023 with a monthly $0.055 per share sponsor contribution to trust and 33% of public shares remaining.
  • MSSA extended its charter through 2/5/2024 with a monthly $0.033 per share sponsor contribution to trust and 49% of public shares remaining.
  • YOTA extended its charter through 4/22/2023 with a single $0.10 per share sponsor contribution to trust.
  • ONYX extended its charter through 8/7/2023 with a monthly $0.029 per share sponsor contribution to trust and 16% of public shares remaining.
  • NRAC extended its charter through 9/4/2023 with a monthly $0.055 per share sponsor contribution to trust and less than 1% of public shares remaining.

Upcoming Meetings and Deadlines

  • 1/30/2023 LION Security Matters approval meeting (liquidation deadline 2/8/2023)
  • 1/30/2023 AACI Charter extension meeting
  • 1/31/2023 GSD Charter extension meeting (liquidation deadline 2/9/2023)
  • 1/31/2023 CPAR Accelerated liquidation meeting
  • 1/31/2023 SCMA Charter extension meeting (liquidation deadline 2/1/2023)
  • 1/31/2023 BLUA Charter extension meeting (liquidation deadline 2/2/2023)
  • 2/1/2023 JWSM Charter extension meeting (liquidation deadline 2/4/2023)
  • 2/1/2023 AMCI LanzaTech approval meeting
  • 2/1/2023 SDAC Charter extension meeting (liquidation deadline 2/9/2023)
  • 2/1/2023 PRPC Charter extension meeting (liquidation deadline 2/5/2023)
  • 2/1/2023 SZZL Charter extension meeting (liquidation deadline 2/8/2023)
  • 2/1/2023 BRD Charter extension meeting
  • 2/2/2023 IMAQ Liquidation deadline (pending $0.10 deposit extension)
  • 2/2/2023 BWAQ Liquidation deadline (pending $0.10 deposit extension)
  • 2/2/2023 AAC Charter extension meeting (liquidation deadline 2/4/2023)
  • 2/2/2023 MIT Liquidation deadline
  • 2/2/2023 ASCA Charter extension meeting
  • 2/3/2023 IQMD Charter extension meeting (liquidation deadline 2/9/2023)
  • 2/3/2023 BCSA Charter extension meeting
  • 2/3/2023 VHAQ Suneva Medical approval meeting
  • 2/3/2023 MPRA Charter extension meeting (liquidation deadline 2/8/2023)
  • 2/3/2023 AEHA Ocean Biomedical approval meeting
  • 2/3/2023 VSAC Liquidation deadline (pending optional $0.10 deposit extension)
  • 2/3/2023 KRNL Charter extension meeting (liquidation deadline 2/5/2023)
  • 2/3/2023 LGST Charter extension meeting (liquidation deadline 2/8/2023)
  • 2/3/2023 ATAK Charter extension meeting (liquidation deadline 2/9/2023)
  • 2/5/2023 FRLA Liquidation deadline (pending $0.10 deposit extension)
  • 2/5/2023 MLAI Liquidation deadline (pending $0.033 deposit extension)
  • 2/6/2023 QFTA Charter extension meeting (liquidation deadline 2/9/2023)
  • 2/6/2023 PMGM Charter extension meeting (liquidation deadline 2/11/2023)
  • 2/6/2023 MCAA Charter extension meeting (liquidation deadline 2/9/2023)
  • 2/7/2023 MCAE ETAO International Group approval meeting (outside date 2/20/2023)
  • 2/7/2023 MURF Liquidation deadline (pending $0.10 deposit extension)
  • 2/7/2023 BACA Charter extension meeting (liquidation deadline 3/30/2023)
  • 2/7/2023 HHLA Charter extension meeting (liquidation deadline 2/9/2023)
  • 2/7/2023 PUCK Charter extension meeting (liquidation deadline 2/16/2023)
  • 2/7/2023 CPTK Charter extension meeting (liquidation deadline 2/11/2023)
  • 2/7/2023 MACA Charter extension meeting (liquidation deadline 2/19/2023)
  • 2/7/2023 DNZ Liquidation at ~$10.17 per share
  • 2/8/2023 BWAC Charter extension meeting (liquidation deadline 2/17/2023)
  • 2/8/2023 WQGA Charter extension meeting (liquidation deadline 2/13/2023)
  • 2/8/2023 ACAC Charter extension meeting
  • 2/8/2023 DHAC Liquidation deadline (pending $0.03 deposit extension)
  • 2/8/2023 IPAX Intuitive Machines approval meeting
  • 2/8/2023 PFDR Movella approval meeting
  • 2/8/2023 ITQ Liquidation deadline
  • 2/8/2023 IRRX Charter extension meeting (liquidation deadline 2/15/2023)
  • 2/8/2023 LIBY Liquidation deadline (pending $0.10 deposit extension)
  • 2/8/2023 TOAC Liquidation deadline (pending $0.10 deposit extension)
  • 2/9/2023 TWND Liquidation deadline (pending $0.02 deposit extension)
  • 2/9/2023 ANZU Charter extension meeting
  • 2/9/2023 ADOC Charter extension meeting (liquidation deadline 2/12/2023)
  • 2/9/2023 GSQD Liquidation at ~$10.18 per share
  • 2/10/2023 NVSA Charter extension meeting (liquidation deadline 2/19/2023)
  • 2/11/2023 EVGR Liquidation deadline (pending $0.10 deposit extension)
  • 2/11/2023 ADRA Liquidation deadline
  • 2/11/2023 CPAQ Liquidation deadline (pending $0.10 deposit extension)
  • 2/12/2023 LGAC Liquidation deadline
  • 2/12/2023 SCOB Liquidation at ~$10.20 per share
  • 2/12/2023 GVCI Liquidation deadline (pending $0.10 deposit extension)
Disclosures: Site administrators may maintain positions in various SPAC securities and may trade in or out of those securities at any time without notice. Information from spacresearch.com is provided for informational purposes only and should not be relied upon as the basis for any investment decision. Nothing on spacresearch.com is a recommendation or solicitation to buy or sell any investment.
Copyright © 2022 SPAC Research, All rights reserved. SPAC Research is the source of all data unless otherwise noted.

Did we miss something important? Please contact us.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.